Stock FDMT 4D MOLECULAR THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions 4D Molecular Therapeutics, Inc.

Equities

FDMT

US35104E1001

Real-time Estimate Cboe BZX
Other stock markets
 01:24:32 2024-05-02 pm EDT 		5-day change 1st Jan Change
26.3 USD +3.58% Intraday chart for 4D Molecular Therapeutics, Inc. +11.43% +29.42%
Apr. 15 Barclays Starts 4D Molecular Therapeutics With Overweight Rating, $45 Price Target MT
Apr. 15 RBC Raises Price Target on 4D Molecular Therapeutics to $40 From $35, Keeps Outperform Rating, Speculative Risk Qualifier MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. FDMT Stock
  4. Revisions 4D Molecular Therapeutics, Inc.